Protiveris licenses Oak Ridge sensor technology

Dec. 4, 2003 — Protiveris Inc., a Maryland-based developer of bioMEMS technology for protein research and drug discovery, has acquired commercial rights to sensor technologies developed at Oak Ridge National Laboratory, according to a news release.

null

Protiveris will apply the technologies to microcantilever measurements of biomolecular interactions. The company will work with Oak Ridge on commercial development and use of Protiveris’ VeriScan 3000 System, a biosensor system capable of detecting multiple biomolecular interactions in drug research and development.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.